CXCL10 and COVID-19: Current research indicates that COVID-19 patients with coexisting MAFLD exhibit a distinct cytokine profile, characterized by elevated levels of interleukin (IL)-6, IL-8, IL-10, and C-X-C motif chemokine ligand 10 (CXCL10), all of which are implicated in a more severe clinical presentation [8,9,10].